Diabetes mellitus and aortic stenosis head to head: toward personalized medicine in patients with both pathologies

Nerea Corbacho-Alonso1, Tamara Sastre-Oliva1, Luis F López-Almodovar2

  • 1Department of Vascular Physiopathology, Hospital Nacional de Paraplejicos, Instituto de Investigación Sanitaria de Castilla-La Mancha (IDISCAM), Spain.

Insights

Diabetes mellitus (DM) accelerates aortic valve calcification by altering valve tissue proteins. This research clarifies the link between diabetes and heart valve disease, aiding personalized patient care.

Area of Science:

  • Cardiology
  • Endocrinology
  • Proteomics

Background:

  • Diabetes mellitus (DM) and calcific aortic stenosis (CAS) are prevalent in the elderly.
  • DM is linked to increased CAS risk, but its precise influence on CAS progression is unclear.

Purpose of the Study:

  • To investigate how DM affects aortic valve tissue and calcification processes.
  • To identify potential therapeutic targets for managing CAS in diabetic patients.

Main Methods:

  • Proteomic analysis using isobaric tags on calcified and noncalcified aortic valve tissues from patients with and without DM.
  • Plasma protein concentrations were measured using three orthogonal methods.
  • A separate cell model was utilized for validation.

Main Results:

  • Proteomic analysis revealed differentially expressed proteins in aortic valves of patients with DM.
  • These proteins are involved in endopeptidase activity, lipid metabolism, coagulation, and fibrinolysis.
  • DM significantly alters the aortic valve proteome, influencing calcification.

Conclusions:

  • Diabetes mellitus induces specific proteomic changes in aortic valves, contributing to calcification.
  • Understanding these DM-driven alterations enhances knowledge of CAS pathogenesis.
  • This research is crucial for developing personalized treatment strategies for patients with concurrent DM and CAS.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
16
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
322
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
39
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
29
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
15